Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on October 2, 2025
Angels for Change Announces 2025 Change Maker of the Year: Vimala Raghavendran
Global nonprofit honors USP leader for groundbreaking work strengthening the medicine supply and access to lifesaving drugs TAMPA, FL, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- Angels for Change (A4C), a global nonprofit dedicated to ending …
What the New ACA Bill Means and How Health Sharing Offers a Practical Alternative in 2025
With ACA changes raising costs and cutting access, MPB Health provides year-round enrollment, lower rates, and smarter care. BOCA RATON, FL, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- Healthcare in America is once again at a crossroads. The …
InfuCare Rx® Opens New Bradenton Infusion Suite to Deliver Patient-Centered Care
BRADENTON, FL, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- InfuCare Rx® is proud to announce the opening of its newest state-of-the-art infusion suite located in the Parkside Professional Plaza at 2902 59th Street West, Suite S, Bradenton, FL …
Mindcore Technologies Highlights Growing Demand for Secure Workspace Solutions Across Regulated Industries
Mindcore Technologies showcases how secure workspace solutions help healthcare, finance, legal, and other industries protect data and ensure compliance. DELRAY BEACH, FL, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- Mindcore Technologies, a …
Tampa Plastic Surgeon on Choosing a Provider
Dr. Dana Coberly details what factors to consider when selecting a plastic surgeon, including qualifications, experience, and more. TAMPA, FL, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- Deciding to undergo plastic surgery is a deeply personal …
DermaSensor Secures $16M to Scale AI-Powered Skin Cancer Detection in Primary Care
DermaSensor Inc. announced it has raised $16 million in Series B funding to fuel the commercial expansion of its FDA cleared, skin cancer detection solution. MIAMI, FL, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- DermaSensor Inc., a medical …
Vireo Growth Inc. Enters into Definitive Agreements to Acquire Outstanding Senior Secured Convertible Notes of Schwazze
MINNEAPOLIS, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF) today announced that it has entered into definitive agreements to acquire approximately 86% of the outstanding senior secured convertible …
VA and DoD contract brings FDA-registered safe patient handling equipment to clinics nationwide
A new VA and DoD contract provides FDA-registered VELA Medical Chairs to clinics nationwide, improving patient and staff safety. TAMPA, FL, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- Safe patient handling has long been a priority in U.S. …
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration …
BEYOND IMMORTALITY: European Wellness Biomedical Group Unveils Landmark Research on Longevity Through Cell Regeneration Over Organ Transplants
From hot-mic whispers of World Leaders to groundbreaking science, Prof. Mike Chan reveals why cellular regeneration — not organ swaps, holds the key to extending human healthspan and lifespan. A Whisper in Beijing BEIJING, Oct. 02, 2025 (GLOBE NEWSWIRE) -- …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
Cardiff Oncology to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will …
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases …
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …
Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on September 30, 2025, the Company exchanged the full $11.48 million …
Dyne Therapeutics Appoints Brian Posner to its Board of Directors
WALTHAM, Mass., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the appointment …
Palisade Bio Announces Closing of Upsized $138 Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option
Offering was led by B Group Capital and Columbia Threadneedle Investments with significant participation from Adage Capital Partners LP, ADAR1 Capital Management, Boxer Capital Management, Coastlands Capital, Deep Track Capital, Janus Henderson Investors, …
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …